CARM1 and pancreatic adenocarcinoma: Collectively, the expression of CARM1 was elevated in various cancers including breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), lymphoid neoplasm diffuse large B cell lymphoma (DLBC), colon adenocarcinoma (COAD), glioblastoma multiforme (GBM), esophageal carcinoma (ESCA), LGG (brain lower-grade glioma), HNSC, LUSC, OV (ovarian serous cystadenocarcinoma), rectum adenocarcinoma (READ), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), pancreatic adenocarcinoma (PAAD), and thymoma (THYM), as shown in Figure 2(a).